IGF2BP2 and non-small cell lung carcinoma: To explore the regulatory effect of IGF2BP2 on drug resistance of NSCLC cells, sh-IGF2BP2 was transfected into A549/R and H1299/R cells to knockdown IGF2BP2, sh-NC was used as a negative control for sh-IGF2BP2.